D.E. Shaw & Co
ARKG icon

D.E. Shaw & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

D.E. Shaw & Co’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Sell
134,009
-402,149
-75% -$11.8M ﹤0.01% 2440
2025
Q4 		$15.5M Buy
536,158
+335,424
+167% +$10.1M 0.01% 1413
2025
Q3 		$5.59M Buy
+200,734
New +$5.07M ﹤0.01% 2110

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

D.E. Shaw & Co's ARKG Position: Q1 2026 in Review

D.E. Shaw & Co reduced its ARK Genomic Revolution ETF (ARKG) stake by 75% in Q1 2026, selling an estimated $11.8M and leaving 134,009 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2440.

D.E. Shaw & Co first reported a position in ARKG in Q3 2025 and has held it in 3 quarters since. The position peaked at $15.5M in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • D.E. Shaw & Co held 134,009 shares of ARK Genomic Revolution ETF worth $3.55M as of Q1 2026.
  • D.E. Shaw & Co sold 402,149 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $11.8M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2440 holding.
  • D.E. Shaw & Co first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 3 quarters since.
  • D.E. Shaw & Co's ARK Genomic Revolution ETF position peaked at $15.5M in Q4 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.